Rationale and design of the Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study.
about
Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases.Thromboxane and the thromboxane receptor in cardiovascular disease.TP receptors and oxidative stress hand in hand from endothelial dysfunction to atherosclerosis.Effect of pharmaceutical interventions targeting thromboxane receptors and thromboxane synthase in cardiovascular and renal diseases.Review: Antiplatelet drugs: what comes next?Emerging antiplatelet agents, differential pharmacology, and clinical utility.Discovery, development and effectiveness of coagulation-inhibiting drugs for stroke therapy.Newer antiatherosclerosis treatment strategies.Placebo - More hatred than love.Association of two single nucleotide polymorphisms from genomewide association studies with clinical phenotypes of cerebral ischemia.Results of the PERFORM magnetic resonance imaging study.Hypertension is an independent predictor of mean platelet volume in patients with acute ischaemic stroke.Red cell distribution width does not predict stroke severity or functional outcome.
P2860
Q33685876-DBB71BE5-BE0B-426D-90CE-1182E06B4BEFQ33899567-91E58D8F-ADC9-4079-9BC1-93BBCBD5177DQ34415503-A1AC93AA-D834-4661-998C-6F207E9A22D8Q37588694-AB342FA1-3F5B-4503-BFB1-5120D4F9F83FQ37809630-3B971C76-2002-40C1-A745-4504E09FB0EDQ37979178-D2937013-4169-4B56-B152-209548E4B0DFQ39766399-53EB717A-C55F-4FD6-84EF-381230EB2F04Q42737139-D05340A0-E855-4F2B-BD85-413CB214B46BQ42773566-097F2B2F-D9FF-4117-A634-F4B3B7E7ADF0Q45744933-7A073613-FFFC-4AC7-A6E5-35690F296452Q45880612-D00FFD12-9ED2-4602-B972-1900D4047E02Q46570310-0C718F43-D299-4BC9-BD4E-1D88927DE1B4Q50533514-0C4D9446-CCB5-4876-A2EF-FD1DBB51C02D
P2860
Rationale and design of the Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rationale and design of the Pr ...... chemic Attack (PERFORM) Study.
@en
Rationale and design of the Pr ...... e or Transient Ischemic Attack
@nl
type
label
Rationale and design of the Pr ...... chemic Attack (PERFORM) Study.
@en
Rationale and design of the Pr ...... e or Transient Ischemic Attack
@nl
prefLabel
Rationale and design of the Pr ...... chemic Attack (PERFORM) Study.
@en
Rationale and design of the Pr ...... e or Transient Ischemic Attack
@nl
P356
P1476
Rationale and design of the Pr ...... chemic Attack (PERFORM) Study.
@en
P2093
Michael G Hennerici
PERFORM Study Investigators
P356
10.1159/000209263
P478
27 Suppl 3
P577
2009-05-14T00:00:00Z